OUR AIM IS SIMPLE.
We are here to innovate aesthetics and skin health with effective solutions.
REGEN Biotech is the research-oriented bio-venture company focusing on commercializing products that were co- developed with the Medical Science Center at KIST, Biology Department of KAIST, and many other leading research institutes in Korea.
REGEN Biotech possesses the world’s leading technology of fabricating scaffolds for therapeutic tissue regeneration using biocompatible polymer and regenerative peptides. PowerPol® is the first innovative scaffold for dermal tissue regeneration applied to penile enlargement, and β-infra ® is an early detection kit for kidney disease, developed to detect regenerative protein that is excreted in urine upon kidney damage. Both products have been successfully launched with Korea Food & Drug Administration (KFDA) approval.
The world’s leading technology of fabricating scaffolds for therapeutic tissue regeneration using biocompatible polymer and regenerative peptides.
With its past success in commercializing the outcome from Tissue Engineering research, REGEN Biotech is stepping toward for developing artificial organs like liver as well as cartilages and bones for Transplantation.